Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene

Safety Dermatological Evaluation of Topic Compatibility (Primary and Accumulated Dermical Irritability and Dermical Sensibility) of Dermacyd Wipes

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00371852

Enrollment

Registered

2006-09-04

Start date

2006-05-31

Completion date

Unknown

Last updated

2008-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hygiene

Brief summary

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd wipes.

Interventions

DRUGlactoserum

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Phototypes: I, II, III and IV; * Integral skin test in the region;

Exclusion criteria

* Lactation or gestation * Use of Anti-inflammatory and/or immune-suppression drugs * Personnel history of atopy; * History of sensibilization or irritation for topic products; * Active cutaneous disease; * Use of new drugs and/or cosmetics during the study

Design outcomes

Primary

Measure	Time frame
Score evaluation of the cutaneous reaction, preconized by International Contact Dermatitis Research Group (ICDRG)	—

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026